TABLE 3.
Characteristics of strains selected for MLST
| Strain | RPa | Serotype | Genotype | Source | mef gene | Allele
|
ST | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| aroE | gdh | gki | recP | spi | xpt | ddl | |||||||
| 67/02 | PESxT | 14 | Spain9V-3 | Conjunctivitis | E | 7 | 11 | 10 | 1 | 6 | 8 | 1 | 156 |
| 544/02 | PESxT | 14 | Spain9V-3 | Blood | E | 7 | 5 | 10 | 1 | 6 | 8 | 1 | 144b |
| 673/02 | PESxT | 14 | Spain9V-3 | Blood | E | 7 | 11 | 10 | 1 | 6 | 8 | 1 | 156 |
| 1615/02 | PESxT | 14 | Spain9V-3 | Sputum | E | 7 | 11 | 10 | 1 | 6 | 8 | 1 | 156 |
| 25/99 | PESxT | 14 | Spain9V-3 | Blood | E | 7 | 11 | 10 | 1 | 6 | 8 | 1 | 156 |
| 485/00 | PESxT | 14 | Spain9V-3 | Sputum | E | 7 | 11 | 10 | 1 | 6 | 8 | 1 | 156 |
| 1529/98 | ESxT | 11A | 11A-ST62 | Pus | E | 2 | 5 | 29 | 12 | 16 | 3 | 14 | 62 |
| 2472/02 | ESxT | 11A | 11A-ST62 | Blood | E | 2 | 5 | 29 | 12 | 16 | 3 | 14 | 62 |
| 413/02 | E | 14 | England14-9 | Blood | A | 1 | 5 | 4 | 5 | 5 | 1 | 8 | 9 |
| 1738/02 | E | 14 | England14-9 | CSFc | A | 1 | 5 | 4 | 5 | 5 | 1 | 8 | 9 |
| 2184/01 | E | 14 | England14-9 | CSF | A | 1 | 5 | 4 | 5 | 5 | 1 | 8 | 9 |
| 3208/02 | E | 14 | England14-9 | Blood | A | 1 | 5 | 4 | 5 | 5 | 1 | 5 | 9 |
a
RP, resistance pattern; P, penicillin nonsusceptible (MIC ≥ 0.12μg/ml); E, erythromycin nonsusceptible (MIC ≥ 1 μg/ml); SxT, co-trimoxazole nonsusceptible (MIC ≥ 1/19 μg/ml).
b
Single-locus variant of ST156.
c
CSF, cerebrospinal fluid.